KIMS makes decent market debut, lists at 22.30%premium

Shares of KIMS (Krishna Institute of Medical Sciences) made a decent market debut on Monday. The stock opened for trading at Rs 1,009 on the National Stock Exchange, compared to the issue price of Rs 825, marking a premium of 22.30%. On the BSE, KIMS opened at Rs 1008.90, at a premium of 22.29%.

The Rs 2,143.74 crore-public issue which raised money between June 16 to June 18 received bids for 5,56,55,046 shares as against 1,44,13,073 shares on offer, according to the stock exchange data. The issue was subscribed 3.86 times. The portion reserved for retail investors was subscribed 2.89 times, the qualified institutional buyers category was subscribed 5.26 times and the non-institutional category received 1.89 times subscription.

The IPO comprised of a fresh issue of Rs 200 crore and an offer for sale of up to 2,35,60,538 equity shares. The offer for sale consists of up to 1,60,03,615 equity shares by investor General Atlantic Singapore KH Pte Ltd; 3,87,966 equity shares by Dr Bhaskara Rao Bollineni; 7,75,933 equity shares by Rajyasri Bollineni; 3,87,966 equity shares by Bolllineni Ramanaiah Memorial Hospital; and 60,05,058 shares by other selling shareholders.

The net proceeds from the fresh issue will be utilised for repayment of certain borrowings (Rs 150 crore) availed by the company and its subsidiaries viz KHKPL, SIMSPL and KHEPL; and for general corporate purposes.

Incorporated in 1973, Krishna Institute of Medical Sciences Limited (KIMS) is one of the largest healthcare groups in AP and Telangana. KIMS provides multi-disciplinary healthcare services with a key focus on primary, secondary, & tertiary care in tier 2-3 cities. As of March 31, 2021, it operates through 9 multi-speciality hospitals under the brand name of “KIMS Hospitals” with an aggregate capacity of 3,064 beds.